- Tytuł:
- JULUCA - a new therapeutic opportunity for patients infected with HIV-1
- Autorzy:
-
Cholewa, Krystian
Poleszak, Julita
Wysokińska, Olga
Gędek, Adam
Zaremba, Bartłomiej
Szabat, Przemysław
Milanowska, Joanna - Powiązania:
- https://bibliotekanauki.pl/articles/1070873.pdf
- Data publikacji:
- 2019
- Wydawca:
- Przedsiębiorstwo Wydawnictw Naukowych Darwin / Scientific Publishing House DARWIN
- Tematy:
-
AIDS
HIV
Juluca
dolutegravir
new treatment
rilpivirine - Opis:
- Although there are currently known treatments for AIDS patients, the virus is still evolving, which means that it is not always possible to eradicate it from an infected organism. The FDA approved in November 2017 the first, complete treatment regimen containing two drugs: dolutegravir and rilpivirine (Juluca). The following article discusses current knowledge about a new, innovative drug as well as future therapeutic options of HIV-1 patients. The preparation can be used as a complete treatment regimen for HIV-1 infection to replace the current antiretroviral regimen in adults who have been virologically inhibited for at least 6 months. Clinical studies of this preparation show that the drug is well tolerated, is metabolizable and offers additional benefits, such as improving the lipid profile, improving bone mineral density and reduced bone resorption. Undoubtedly, longer observation of the effects of this drug therapy is needed, but this dual scheme seems to be a promising strategy for patients infected with HIV.
- Źródło:
-
World Scientific News; 2019, 123; 181-191
2392-2192 - Pojawia się w:
- World Scientific News
- Dostawca treści:
- Biblioteka Nauki
Artykuł